News search

• Adiponectin, secreted by adipose tissue, protects against the development of the main form of liver cancer
• Women produce the hormone in larger quantities than men, and adiponectin release also declines in people with obesity
• The results open the route to combating a cancer for which there is currently no treatment and that is the fourth cause of death in the world.

The results, published in JACC, demonstrate the potential of this technology to generate images of the inflammation associated with systemic atherosclerosis; this information will be useful for the study of early stages of this disease and will help to identify individuals who will benefit from early medical intervention

The results have implications for patient prognosis, since detection of this marker can prompt intervention to prevent irreversible damage

Neutrophils are the body’s main line of defense, but their action can also damage healthy cells in the cardiovascular system

The study, published in Immunity, shows that some intestinal bacteria, such as Lactobacillus, strengthen the intestinal barrier by interacting with an immune cell receptor called Mincle (Clec4e)

• ·         The Pro CNIC Foundation prolongs its commitment until 2028, with the excellent cardiovascular research carried out at the CNIC under the management of Dr. Valentín Fuster
• ·         The innovative public-private financing formula has allowed the CNIC to reach a very high level of excellence, making it worthy of the Severo Ochoa accreditation and other international recognitions 
  
• The Pro CNIC joins together 12 of the most important companies in Spain: Acciona, Santander Bank, BBVA, Endesa, Mapfre Foundation, Mutua Madrileña Foundation, Ramón Areces Foundation, Repsol Foundation, Inditex, "la Caixa", Prisa and Telefónica.

The expression on lymphocytes of the molecule CD69 inversely predicts the development of subclinical (symptom-free) atherosclerosis independently of classical cardiovascular risk factors

The scientific event, which took place in Madrid, brought together more than 100 researchers from different fields of cardiovascular biology